Grove Collaborative Holdings, Inc. Class A GROV 深 滬
已收盤 02-06 16:00:00 美东时间
1.53
+0.050
+3.38%
華盛通- 最 高1.55
- 今 開1.50
- 成交量 16.72万股
- 最 低 1.50
- 昨 收 1.48
- 總市值 6332.31万
- 52周最高 1.84
- 市盈率 靜 --
- 換手率 0.40%
- 52周最低 1.022
- 委 比 -92.31%
- 總股本 4138.77万
- 歷史最高 62.515
- 量 比 3.97
- 振 幅 3.38%
- 歷史最低 0.9075
- 每 手 1
- 風險率 0.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Grove Collaborative Hldgs Sees FY2025 Sales $172.500M-$175.000M vs $181.900M Est
Grove Collaborative Hldgs (NYSE:GROV) sees FY2025 sales of $172.500 million-$175.000 million vs $181.900 million analyst estimate.
2025-11-14 05:13
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
Canaccord Genuity Maintains Buy on Grove Collaborative Hldgs, Raises Price Target to $2
Canaccord Genuity analyst Susan Anderson maintains Grove Collaborative Hldgs (NYSE:GROV) with a Buy and raises the price target from $1.5 to $2.
2025-11-12 02:19
Grove Collaborative Amends Loan Agreement for Flexibility
Grove Collaborative Holdings ( ($GROV) ) has provided an update. On September 2...
2025-10-01 04:49
Grove Collaborative Appoints New Audit Committee Chair
Grove Collaborative Holdings ( ($GROV) ) has shared an announcement. On August ...
2025-08-26 04:42
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
2025-08-11 09:43
Canaccord Genuity Maintains Buy on Grove Collaborative Hldgs, Lowers Price Target to $1.5
Canaccord Genuity analyst Susan Anderson maintains Grove Collaborative Hldgs (NYSE:GROV) with a Buy and lowers the price target from $3 to $1.5.
2025-08-09 05:46
Grove Collaborative soars after activist investor calls for a strategic review
Grove Collaborative Holdings (NYSE:GROV) rallied on Wednesday after activist investor HumanCo Investments sent a public letter to the company's board of directors calling for a comprehensive review ...
2025-07-10 01:37
HumanCo Urges Grove Collaborative To Pursue Strategic Alternatives Including Full Sale; Estimates $2.25–$2.90/Share Valuation, A 90–140% Premium To Current Price
Strategic alternatives, including a full sale of the business, must be pursued in order to unlock the full value of the platform.Believes Grove could be conservatively valued at ~0.70x - 0.90x 2025E revenue in such a
2025-07-09 04:17
